L-lactic acid/Citric acid/Potassium bitartrate

L-乳酸/柠檬酸/酒石酸氢钾

Report date: 2022/12/16 14:36:15
QIDP

Base Information

Drug NameL-lactic acid/Citric acid/Potassium bitartrate
Drug Alias NameL-lactic acid+Citric acid+Potassium bitartrate柠檬酸L-乳酸L-lactic acid, Citric acid and Potassium bitartrateL-乳酸，柠檬酸和酒石酸氢钾 +[18] 
ClassificationSmall molecules
Mechanisms of ActionInflammation mediators modulators
TargetsInflammation mediators
Therapy Area/IndicationsContraceptionHIV InfectionsSexually Transmitted Diseases +[7] 
Global Approved IndicationsContraception
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2020/05/22
Country/TerritoryUnited StatesRussian Federation
CombinationsYes Lactic acidCitric AcidPotassium Bitartrate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEvofem Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Hawaiʻi FoundationEvofem Inc
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsContraceptionSexually Transmitted DiseasesCandidiasis, Vulvovaginal +[6] 
Inactive IndicationsHIV Infections

Other Information

ATC CodeG02BB
Related LinksN/A